614 related articles for article (PubMed ID: 11528389)
1. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
Savkur RS; Philips AV; Cooper TA
Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
3. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
Nakamori M; Kimura T; Fujimura H; Takahashi MP; Sakoda S
Muscle Nerve; 2007 Aug; 36(2):251-7. PubMed ID: 17487865
[TBL] [Abstract][Full Text] [Related]
4. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
Ho TH; Bundman D; Armstrong DL; Cooper TA
Hum Mol Genet; 2005 Jun; 14(11):1539-47. PubMed ID: 15843400
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy.
Ohsawa N; Koebis M; Suo S; Nishino I; Ishiura S
Biochem Biophys Res Commun; 2011 May; 409(1):64-9. PubMed ID: 21549096
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
[TBL] [Abstract][Full Text] [Related]
8. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
[TBL] [Abstract][Full Text] [Related]
11. RNA pathogenesis of the myotonic dystrophies.
Day JW; Ranum LP
Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
[TBL] [Abstract][Full Text] [Related]
12. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
13. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts.
Takarada T; Nishida A; Takeuchi A; Lee T; Takeshima Y; Matsuo M
Brain Dev; 2015 Aug; 37(7):661-8. PubMed ID: 25476247
[TBL] [Abstract][Full Text] [Related]
15. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice.
Guiraud-Dogan C; Huguet A; Gomes-Pereira M; Brisson E; Bassez G; Junien C; Gourdon G
Biochim Biophys Acta; 2007 Dec; 1772(11-12):1183-91. PubMed ID: 17950578
[TBL] [Abstract][Full Text] [Related]
16. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.
Rudnicki DD; Holmes SE; Lin MW; Thornton CA; Ross CA; Margolis RL
Ann Neurol; 2007 Mar; 61(3):272-82. PubMed ID: 17387722
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophy expanded CUG repeats disturb the expression and phosphorylation of tau in PC12 cells.
Hernández-Hernández O; Bermúdez-de-León M; Gómez P; Velázquez-Bernardino P; García-Sierra F; Cisneros B
J Neurosci Res; 2006 Sep; 84(4):841-51. PubMed ID: 16862553
[TBL] [Abstract][Full Text] [Related]
18. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Klinck R; Rocheleau L; Pelchat M; Chabot B; Jasmin BJ; Côté J
PLoS Genet; 2016 Jan; 12(1):e1005827. PubMed ID: 26824521
[TBL] [Abstract][Full Text] [Related]
19. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
20. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions.
Furling D; Doucet G; Langlois MA; Timchenko L; Belanger E; Cossette L; Puymirat J
Gene Ther; 2003 May; 10(9):795-802. PubMed ID: 12704419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
